| Literature DB >> 35189018 |
Jennifer Philip1,2,3, Olivia Wawryk1, Leeanne Pasanen2, Aaron Wong2,3, Stephanie Schwetlik4, Anna Collins1.
Abstract
BACKGROUND: In Australia during the COVID-19 pandemic new funding models were introduced to support telehealth consultations, resulting in their widescale adoption in palliative care service delivery. Clarity around the clinical circumstances and patient populations that might be most appropriate for telehealth models was required. AIMS: To evaluate patient and physician satisfaction, acceptability and utility of outpatient palliative care provision through telehealth.Entities:
Keywords: COVID-19; outpatient; palliative care; survey and questionnaire; telemedicine
Mesh:
Year: 2022 PMID: 35189018 PMCID: PMC9540442 DOI: 10.1111/imj.15721
Source DB: PubMed Journal: Intern Med J ISSN: 1444-0903 Impact factor: 2.611
Covariates of interest
| Patient‐reported demographics | |
| Age, gender, country of birth, language spoken at home | |
| Postcode was used to determine relative socioeconomic disadvantage | Reported in quintiles, higher scores representing lowest disadvantage |
| Clinician‐reported clinical characteristics | |
| Primary diagnosis | |
| Performance status | Australian‐modified Karnofsky Performance Status (AKPS) |
| Palliative care outcome collaborative (PCOC) phase of care | Stable, unstable, deteriorating, terminal |
| Palliative Care Problem Severity Scores (PSS) | Pain, other symptoms, psychological/spiritual distress, family/carer distress |
| Consultation characteristics (completed by patients and clinicians) | |
| Mode of delivery | Audio only versus audio and visual |
| Reason for appointment | |
| Action instituted in response to each of the problems as listed in PSS (pain, other symptoms, psychological/spiritual distress and family/carer distress) | Continue care (with no/minimal changes to management); monitor and record (limited changes made to management but requiring close surveillance); review/change plan of care, referral, intervention (significant change in management required with monitoring); or urgent action required (immediate and significant change in management required) |
| Time spent | During consultation |
| Follow‐up care | |
| Outcome measures | |
| Patient‐reported telehealth usability/utility | Telehealth Usability Questionnaire (TUQ), a 21‐item patient‐reported measure capturing five domains of the usability on a 7‐point Likert scale: usefulness, ease of use, effectiveness, reliability and satisfaction |
| Patient‐ and clinician‐reported acceptability | A 5‐point Likert scale, from 1 (very unacceptable) to 5 (very acceptable) |
| Patient‐ and clinician‐reported satisfaction | A 5‐point Likert scale, from 1 (very unacceptable) to 5 (very acceptable) |
Cohort demographics
| Characteristic | Matched clinician–patient cohort, | Clinician‐only cohort, |
|---|---|---|
| Demographic | ||
| Age (years) | 63.50 (52–70) | NR |
| Female | 77 (61) | |
| Born in Australia | 86 (68) | |
| Regionality | ||
| Major cities | 105 (84) | |
| Inner regional | 17 (14) | |
| Outer regional | 3 (2) | |
| IRSD quintile (higher represents lowest disadvantage) | ||
| 1 | 13 (10) | |
| 2 | 13 (10) | |
| 3 | 21 (17) | |
| 4 | 33 (26) | |
| 5 | 45 (36) | |
| Speak a language other than English at home | 26 (21) | |
| Interpreter present | 2 (2) | |
| First palliative care consultation through telehealth | 53 (42) | |
| Clinical | ||
| Primary life‐limiting illness | ||
| Advanced cancer | 118 (93) | 766 (95) |
| Neurodegenerative disease | 1 (0.8) | 6 (0.7) |
| Renal failure | 6 (4.7) | 16 (2.0) |
| Respiratory failure | 1 (0.8) | 7 (0.9) |
| Hepatic failure | 0 | 1 (0.1) |
| Cardiac failure | 0 | 4 (0.5) |
| Other | 1 (0.8) | 8 (1.0) |
| PCOC phase | ||
| Stable | 79 (62) | 436 (54) |
| Unstable | 27 (21) | 186 (23) |
| Deteriorating | 20 (16) | 171 (21) |
| Terminal | 1 (1) | 18 (2) |
| Pain: PSS | ||
| Continue care | 54 (43) | 306 (38) |
| Monitor and record | 25 (20) | 163 (20) |
| Review/change plan of care; referral, intervention | 46 (37) | 327 (41) |
| Urgent action | 1 (1) | 11 (1) |
| Other symptoms: PSS | ||
| Continue care | 55 (43) | 343 (43) |
| Monitor and record | 37 (29) | 223 (28) |
| Review/change plan of care; referral, intervention | 35 (28) | 231 (29) |
| Urgent action | 0 | 11 (1) |
| Psychological/spiritual: PSS | ||
| Continue care | 80 (63) | 462 (57) |
| Monitor and record | 32 (25) | 258 (32) |
| Review/change plan of care; referral, intervention | 14 (11) | 87 (11) |
| Urgent action | 1 (1) | 0 |
| Family/carer: PSS | ||
| Continue care | 89 (71) | 509 (64) |
| Monitor and record | 32 (26) | 221 (28) |
| Review/change plan of care; referral, intervention | 4 (3) | 72 (9) |
| Urgent action | 0 | 0 |
| AKPS | ||
| ≤50 | 21 (17) | 198 (25) |
| 50–70 | 44 (36) | 355 (45) |
| 70–100 | 57 (47) | 238 (30) |
| Consultation characteristics | ||
| Mode of telehealth | ||
| Audio and visual | 49 (31) | 206 (27) |
| Audio only | 88 (69) | 567 (73) |
| Family member/carer present | 58 (46) | NR |
| Time spent during consultation, median (IQR) (min) | 30 (11.7) | 20 (15, 30) |
| Time spent coordinating follow‐up care, median (IQR) (min) | 12.2 (10.1) | 10 (5, 15) |
| Reason for appointment | ||
| Introduction to palliative care | 7 (6) | 19 (2) |
| Provision of pain and symptom management | 73 (58) | 508 (63) |
| Goals of care discussion | 6 (5) | 14 (2) |
| Advance care planning | 2 (2) | 7 (1) |
| Routine review/follow up | 38 (30) | 244 (30) |
| Community PC referral | 0 | 5 (1) |
| Other | 0 | 12 (2) |
AKPS, Australia‐modified Karnofsky Performance Status; IQR, interquartile range; IRSD, Index of Relative Socio‐economic Disadvantage; NR, not reported by clinicians; PC, palliative care; PCOC, palliative care outcome collaborative; PSS, Palliative Care Problem Severity Score.
Acceptability and satisfaction reported by patients and clinicians in the matched cohort
| Acceptability of the telehealth consultation today ( | |||||||
|---|---|---|---|---|---|---|---|
| Very unacceptable | Somewhat unacceptable | Undecided | Somewhat acceptable | Very acceptable | Overall Acceptable | Discordant views | |
| Patient reported | 0 | 6 (4.7) | 5 (3.9) | 31 (24.4) | 85 (66.9) |
| 23 (18.1) |
| Clinician reported | 2 (1.6) | 12 (9.5) | 4 (3.1) | 50 (39.4) | 59 (46.5) |
| |
Discordance is based on binary yes/no.
Patient perceptions of utility of telehealth (Telehealth Usability Questionnaire (TUQ))
| Perceptions of utility of telehealth (TUQ) | All participants ( | Audio only ( | Audio and visual ( |
|
|---|---|---|---|---|
| Usefulness | 5.96 (1.08) | 5.84 (1.08) | 6.22 (1.06) | 0.07 |
| Telehealth improves my access to healthcare services | 5.91 (1.36) | 5.76 (1.36) | 6.26 (1.31) | 0.06 |
| Telehealth saves me time travelling to a hospital or specialist clinic | 6.48 (0.98) | 6.36 (1.02) | 6.73 (0.84) | 0.06 |
| Telehealth provides for my healthcare need | 5.52 (1.48) | 5.43 (1.43) | 5.74 (1.61) | 0.28 |
| Ease of use and learnability | 5.70 (1.50) | 5.52 (1.46) | 6.13 (1.53) | 0.03 |
| It was simple to use this system | 6.10 (1.44) | 6.07 (1.35) | 6.16 (1.68) | 0.74 |
| It was easy to learn to use the system | 6.00 (1.52) | 5.90 (1.52) | 6.24 (1.52) | 0.25 |
| I believe I could become productive quickly using this system | 5.38 (1.86) | 5.13 (1.87) | 6.00 (1.70) | 0.02 |
| The way I interact with this system is pleasant | 5.69 (1.67) | 5.49 (1.65) | 6.14 (1.67) | 0.05 |
| I like using the system | 5.30 (1.93) | 4.97 (1.96) | 6.08 (1.63) | <0.01 |
| The system is simple and easy to understand | 5.72 (1.79) | 5.58 (1.78) | 6.03 (1.79) | 0.21 |
| This system is able to do everything I would want it to be able to do | 5.08 (1.90) | 4.84 (1.87) | 5.65 (1.86) | 0.03 |
| Effectiveness | 5.59 (1.45) | 5.51 (1.43) | 5.77 (1.48) | 0.36 |
| I can easily talk to the clinician using the telehealth system | 5.76 (1.51) | 5.57 (1.56) | 6.22 (1.29) | 0.03 |
| I can hear the clinician clearly using the telehealth system | 5.94 (1.45) | 5.90 (1.43) | 6.03 (1.52) | 0.65 |
| I felt I was able to express myself effectively | 5.81 (1.46) | 5.65 (1.50) | 6.19 (1.31) | 0.06 |
| I can see the clinician as well as in person | − | 5.16 (1.65) | − | – |
| Reliability | 4.26 (1.87) | 4.05 (1.97) | 4.74 (1.52) | 0.06 |
| I think the visits provided over the telehealth system are the same as in‐person | 4.00 (2.02) | 3.88 (2.09) | 4.29 (1.83) | 0.29 |
| Whenever I made a mistake using the system, I could recover easily and quickly | 4.63 (2.22) | 4.28 (2.29) | 5.50 (1.76) | <0.01 |
| The system gave error messages that clearly told me how to fix problems | − | − | 4.59 (2.34) | – |
| Satisfaction and future use | 5.51 (1.70) | 5.25 (1.70) | 6.10 (1.58) | <0.01 |
| I feel comfortable communicating with the clinician using the telehealth system | 5.60 (1.73) | 5.40 (1.69) | 6.08 (1.75) | 0.04 |
| Telehealth is an acceptable way to receive healthcare services | 5.19 (1.95) | 4.94 (1.96) | 5.76 (1.82) | 0.03 |
| I would use telehealth services again | 5.72 (1.68) | 5.44 (1.72) | 6.34 (1.44) | <0.01 |
| Overall, I am satisfied with this telehealth system | 5.54 (1.82) | 5.25 (1.87) | 6.18 (1.54) | <0.01 |
Scores range from 1 to 7 for each question and subscale on the TUQ.
Two‐sided t‐test was used to compare mean scores between groups and test for significance.
Univariate factors associated with patient‐ and clinician‐reported acceptability of telehealth in the matched cohort (n = 127)
| Predictor | Patient‐reported acceptability | Clinician‐reported acceptability | ||||||
|---|---|---|---|---|---|---|---|---|
| OR |
| 95% CI | OR |
| 95% CI | |||
| Patient aged over 80 years | 0.49 | 0.53 | 0.05 | 4.54 |
|
|
|
|
| Female | 2 | 0.27 | 0.58 | 6.98 | 0.62 | 0.39 | 0.2 | 1.87 |
| Born in Australia | 0.44 | 0.31 | 0.09 | 2.13 | 1.4 | 0.52 | 0.5 | 2.93 |
| Language other than English | 1.17 | 0.84 | 0.24 | 5.79 |
|
|
|
|
| Regional home residence | 2 | 0.52 | 0.24 | 16.56 | 3.45 | 0.25 | 0.23 | 27.34 |
| First telehealth appointment | 0.86 | 0.81 | 0.25 | 2.98 | 0.31 | 0.28 | 0.11 | 0.88 |
| Family member present | 3.41 | 0.08 | 0.86 | 13.53 |
|
|
|
|
| Audio and visual telehealth link | 1.16 | 0.83 | 0.29 | 4.66 | 2.4 | 0.19 | 0.65 | 8.82 |
| AKPS > 40 | 1.13 | 0.91 | 0.13 | 9.88 | 2.77 | 0.17 | 0.65 | 11.91 |
| PCOC phase | ||||||||
| Stable | 1 | − | ref | 1 | – | ref | ||
| Unstable | 1.03 | 0.98 | 0.19 | 5.42 |
|
|
|
|
| Deteriorating | 0.47 | 0.31 | 0.11 | 2.05 |
|
|
|
|
| Terminal | 1 | – | (omitted) | 1 | – | (omitted) | ||
| Pain PSS | ||||||||
| Continue care | 1 | – | ref | 1 | – | ref | ||
| Monitor and record |
|
|
|
| 0.43 | 0.33 | 0.08 | 2.31 |
| Review/change plan of care | 1.29 | 0.78 | 0.21 | 8.1 |
|
|
|
|
| Urgent action | 1 | − | (omitted) | 1 | – | (omitted) | ||
| Other PSS | ||||||||
| Continue care | 1 | − | ref | 1 | – | ref | ||
| Monitor and record |
|
|
|
| 1.65 | 0.49 | 0.39 | 6.85 |
| Review/change plan of care | 0.4 | 0.33 | 0.06 | 2.54 | 0.49 | 0.21 | 0.16 | 1.51 |
| Psychological PSS | ||||||||
| Continue care | 1 | − | ref | 1 | – | ref | ||
| Monitor and record | 0.67 | 0.55 | 0.18 | 2.47 | 0.38 | 0.074 | 0.13 | 1.09 |
| Review/change plan of care | 1 | − | (omitted) | 1.64 | 0.65 | 0.19 | 14.13 | |
| Urgent action | 1 | − | (omitted) | 1 | – | (omitted) | ||
| Family PSS | ||||||||
| Continue care | 1 | − | ref | 1 | – | ref | ||
| Monitor and record |
|
|
|
|
|
|
|
|
| Review/change plan of care | 1 | − | (omitted) | 0.34 | 0.37 | 0.03 | 3.59 | |
| Reason for review | ||||||||
| Introduction to palliative care |
|
|
|
| 0.29 | 0.1 | 0.07 | 1.29 |
| Routine review | 2.02 | 0.38 | 0.42 | 9.85 |
|
|
|
|
| Goals of care discussion |
|
|
|
| 0.47 | 0.37 | 0.09 | 2.51 |
Bold values are statistically significant. AKPS, Australia‐modified Karnofsky Performance Status; CI, confidence interval; OR, odds ratio; PCOC, Palliative care outcome collaborative; PSS, Palliative Care Problem Severity Score.
Univariate factors associated with patient‐ and clinician‐reported satisfaction of telehealth in the matched cohort (n = 127)
| Patient‐reported satisfaction | Clinician‐reported satisfaction | |||||||
|---|---|---|---|---|---|---|---|---|
| Predictor | OR |
| 95% CI | OR |
| 95% CI | ||
| Patient aged over 80 years | 0.96 | 0.96 | 0.18 | 5.19 | 0.7 | 0.65 | 0.15 | 3.28 |
| Female | 1.62 | 0.23 | 0.74 | 3.55 | 0.54 | 0.12 | 0.25 | 1.17 |
| Born in Australia | 1.07 | 0.87 | 0.47 | 2.43 | 1.47 | 0.33 | 0.68 | 3.16 |
| Language other than English | 0.69 | 0.43 | 0.28 | 1.73 |
|
|
|
|
| Regional home residence |
|
|
|
| 2.36 | 0.15 | 0.74 | 7.58 |
| First telehealth appointment | 0.75 | 0.46 | 0.34 | 1.62 | 0.49 | 0.06 | 0.23 | 1.02 |
| Family member present | 1.97 | 0.09 | 0.89 | 4.32 | 1.55 | 0.25 | 0.74 | 3.2 |
| Audio and visual telehealth link | 1.5 | 0.38 | 0.62 | 3.53 |
|
|
|
|
| AKPS > 40 | 0.6 | 0.53 | 0.12 | 2.97 | 1.2 | 0.79 | 0.32 | 4.51 |
| PCOC phase | ||||||||
| Stable | 1 | – | ref | 1 | – | ref | ||
| Unstable | 1.44 | 0.49 | 0.51 | 4.02 |
|
|
|
|
| Deteriorating | 0.76 | 0.61 | 0.27 | 2.16 |
|
|
|
|
| Terminal | 1 | – | (omitted) | 1 | – | (omitted) | ||
| Pain PSS | ||||||||
| Continue care | 1 | – | ref | 1 | – | ref | ||
| Monitor and record | 0.46 | 0.12 | 0.17 | 1.21 |
|
|
|
|
| Review/change plan of care | 2.35 | 0.09 | 0.87 | 6.34 |
|
|
|
|
| Urgent action | 1 | – | (omitted) | 1 | – | (omitted) | ||
| Other PSS | ||||||||
| Continue care | 1 | – | ref | 1 | – | ref | ||
| Monitor and record |
|
|
|
| 0.5 | 0.13 | 0.2 | 1.22 |
| Review/change plan of care | 0.48 | 0.15 | 0.18 | 1.3 |
|
|
|
|
| Psychological PSS | ||||||||
| Continue care | 1 | ‐ | ref | 1 | ‐ | ref | ||
| Monitor and record | 1.03 | 0.95 | 0.42 | 2.56 |
|
|
|
|
| Review/change plan of care | 1 | 0.99 | 0.29 | 3.54 | 0.64 | 0.47 | 0.19 | 2.13 |
| Urgent action | 1 | – | (omitted) | 1 | – | (omitted) | ||
| Family PSS | ||||||||
| Continue care | 1 | – | ref | 1 | – | ref | ||
| Monitor and record | 1.56 | 0.36 | 0.6 | 4.03 | 0.46 | 0.06 | 0.2 | 1.05 |
| Review/change plan of care | 0.44 | 0.42 | 0.06 | 3.25 | 1.38 | 0.79 | 0.14 | 13.83 |
| Reason for review | ||||||||
| Introduction to palliative care | 0.29 | 0.07 | 0.07 | 1.13 | 0.25 | 0.6 | 0.06 | 1.04 |
| Routine review | 0.96 | 0.92 | 0.41 | 2.22 |
|
|
|
|
| Goals of care discussion |
|
|
|
| 0.91 | 0.9 | 0.21 | 3.99 |
Bold values are statistically significant. AKPS, Australia‐modified Karnofsky Performance Status; CI, confidence interval; OR, odds ratio; PCOC, Palliative care outcome collaborative; PSS, Palliative Care Problem Severity Score.